Kura Oncology ($KURA) Insider Trading & Smart Money Activity
Kura Oncology, Inc. ($KURA) has 10 insider trades and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 7 insiders sold ($2.09M), net -$2.09M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 7
- Net insider $ (12 mo)
- -$2.09M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 2
KURA insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 1 · $834K | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 9 · $1.26M | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All KURA insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Powl Brian T.Chief Commercial Officer | Sell (Open-market sale) 10b5-1 | 15.43K sh | $165.85K | -2.5% | — | |||||
| Insider | Leoni MollieChief Medical Officer | Sell (Open-market sale) 10b5-1 | 28.80K sh | $309.57K | -2.5% | — | |||||
| Insider | Kathleen FordChief Operating Officer | Sell (Open-market sale) 10b5-1 | 3.67K sh | $39.44K | -2.5% | — | |||||
| Insider | Powl Brian T.Chief Commercial Officer | Sell (Open-market sale) 10b5-1 | 17.02K sh | $179.18K | +0.1% | — | |||||
| Insider | Leoni MollieChief Medical Officer | Sell (Open-market sale) | 12.45K sh | $130.67K | +0.1% | — | |||||
| Insider | Kathleen FordChief Operating Officer | Sell (Open-market sale) 10b5-1 | 6.91K sh | $72.49K | +0.1% | — | |||||
| Insider | Doyle Thomas JamesSVP, Finance & Accounting | Sell (Open-market sale) | 4.61K sh | $48.36K | +0.1% | — | |||||
| Insider | Bair Teresa BrophyChief Legal Officer | Sell (Open-market sale) 10b5-1 | 8.44K sh | $88.62K | +0.1% | — | |||||
| Insider | Burrows FrancisChief Scientific Officer | Sell (Open-market sale) | 20.73K sh | $224.51K | -1.9% | — | |||||
| Insider | Mollie LeoniChief Medical Officer | Sell (Open-market sale) 10b5-1 | 84.93K sh | $834K | +4.3% | +7.6% | — | ||||
| Analyst | Citizens | Reiterates to buy | PT $24 | +8.6% | +18.8% | Read | |||||
| Analyst | Citizens | Reiterates to buy | PT $24 | +8.6% | +18.8% | Read |
1W / 1M / 6M = how KURA moved from the trade or filing date.
Insider trading in KURA: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Powl Brian T. | Chief Commercial Officer | 2 | -$345.04K | Sep 29, 2026 | |
| Leoni Mollie | Chief Medical Officer | 2 | -$440.24K | Sep 29, 2026 | |
| Kathleen Ford | Chief Operating Officer | 2 | -$111.93K | Sep 29, 2026 | |
| Doyle Thomas James | SVP, Finance & Accounting | 1 | -$48.36K | Sep 28, 2026 | |
| Bair Teresa Brophy | Chief Legal Officer | 1 | -$88.62K | Sep 28, 2026 | |
| Burrows Francis | Chief Scientific Officer | 1 | -$224.51K | Sep 24, 2026 | |
| Mollie Leoni | Chief Medical Officer | 1 | -$834K | Jun 18, 2026 |
Analyst ratings on KURA
Frequently asked questions
Are KURA insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 7 insiders made 10 open-market sales worth $2.09M, a net -$2.09M.
What is the latest insider trade in KURA?
Powl Brian T., Chief Commercial Officer filed a sell (open-market sale) of 15.43K sh worth $165.85K on Sep 29, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.